CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
EpiGlia focuses on reactivating oligodendroglial cells to delay the onset of Alzheimer’s Disease by utilizing targeted epigenetic tools. The project aims to understand the role of these cells in disease progression and develop non-invasive methods to enhance their function, potentially improving therapeutic strategies…
Alzheimer’s Disease (AD) is the most prominent neurodegenerative disease, representing a major public health issue worldwide.
Unfortunately, the failure rate in clinical trials of AD drugs is one of the highest.
One explanation could be our incompletely understanding of disease onset and progression.
Notably the role of glial cells in AD has been overlooked until recently.EpiGlia aims at reactivating oligodendroglial cells to delay AD onset, by leveraging cell-specific and locus-targeted epigene…
UNIVERSITE D'AIX MARSEILLE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
